Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Therapy Manufacturing Market, 2021-2030.” The report features ..
Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs ..
Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Contract Manufacturing Market, 2020-2030” report to its list ..
The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern ..
More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are over ..
Covid-19 Updates | Subcutaneous Biologic Drugs and Affiliated Technologies Market is projected to be worth over USD 180 billion by 2030
Nearly 300 non-invasive diagnostic tests, designed for the detection of various types of cancers, are either already available in the market or under development ..
Advanced therapy medicinal products, such as cell and gene therapies, have revolutionized healthcare practices. The introduction of such treatment options
Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2021-2030.” The report ..
Roots Analysis has announced the addition of “Global T-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition)-Distribution by Type of Therapy (CAR-T, ..
Medical Device Batteries Market is projected to grow at an annualized rate of 12%, claims Roots Analysis
Roots Analysis has announced the addition of “Global Handheld X-Ray Imaging Devices Market by Area of Application (Dental and Others), Device Class (Low-End, ..
Advances in information technology and biomedical science have enabled the development of digital solutions for biomarkers, which, owing to the myriad ..
Roots Analysis has announced the addition of “Diabetes Monitoring Devices Market, 2020-2030” report to its list of offerings. Over time, a number of companies ..
Diabetes Drug Delivery Devices Market is projected to be worth USD 31 billion by 2030, growing at a CAGR of 9%, claims Roots Analysis
Virtual Clinical Trial Service Providers Market is estimated to be worth USD 12 billion in 2050, predicts Roots Analysis
Targeted Protein Degradation Enabling Technologies Market, featuring a healthy pipeline of novel therapeutics, is anticipated to be worth over USD 3.3 billion ..
Single-Use Bioreactors Market is estimated to be worth USD 6.6 Billion by 2030, growing at an annualized rate of over 18%, claims Roots Analysis
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer ..
Gene Therapy Market is projected to be worth USD 14.6 billion in 2030, growing at a CAGR of 30%, over the next decade, claims Roots Analysis
CAR-T Therapies Market is characterized by a healthy pipeline of promising therapies, and is projected to be worth around USD 14 Billion in 2030, claims ..
Biopharmaceutical Contract Manufacturing Market is projected to be worth USD 32.4 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis
Biopharmaceutical Contract Manufacturing Market is projected to be worth USD 32.4 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis